Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tot'héma in Adults With Moderate Iron Deficiency Anaemia
NCT04309669Phase 4Completed
- Sponsor
- InnoTech Precision Medicine
- Start
- Nov 2020
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferrous gluconate + manganese gluconate + copper gluconate in iron deficiency anemia (IDA), sponsored by InnoTech Precision Medicine. Primary endpoint: Time required for a mean increase of at least 0,5g/dL from baseline in the haemoglobin level at 12 weeks. Started Nov 2020; status: completed.
02
Drugs
ferrous gluconate + manganese gluconate + copper gluconate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04309669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04309669.